TEM Latest Headlines

Tempus Earns Spot on TIME’s 10 Most Influential Health and Life Science Companies—Industry Leadership Brings Focus on AI-Driven Precision Medicine

Market Chameleon (Tue, 28-Apr 8:49 AM)

TEM's Collaboration with USC Targets 1.5 Million Patient Visits and Sets AI-Driven Precision Care in Motion

Market Chameleon (Thu, 23-Apr 8:50 AM)

Tempus Schedules Q1 2026 Results and Business Update, Highlighting AI Progress in Precision Medicine

Market Chameleon (Tue, 21-Apr 8:46 AM)

Tempus Unveils 31 Breakthrough Oncology Insights at AACR 2026, Spotlights AI’s Expanding Role in Precision Medicine

Market Chameleon (Wed, 15-Apr 11:46 AM)

Tempus Unveils Major Data-Led Oncology Advances With 31 Abstracts Accepted at AACR 2026

Market Chameleon (Tue, 14-Apr 8:37 AM)

ARK’s Bold Move: Why Tempus AI Is Becoming a Cornerstone Holdings in Healthcare AI

Market Chameleon (Mon, 30-Mar 9:19 AM)

Tempus and Merck Sign Multi-Year AI Collaboration to Advance Precision Medicine—Strategic Focus on Oncology Biomarker Discovery

Market Chameleon (Tue, 3-Mar 8:35 AM)

Tempus Unveils HRD-RNA Algorithm, Expanding Access to Precision Cancer Therapies

Market Chameleon (Wed, 18-Feb 8:54 AM)

RNA Data Drives Clarity: Ambry Genetics Hits One Million DNA/RNA Tests, Improving Accuracy and Equity in Genetic Diagnostics

Market Chameleon (Mon, 2-Feb 7:09 AM)